Impact evaluation Evaluate new tools Translate new knowledge into policy and implementation Knowledge gap Program implementation.

Slides:

Advertisements

Similar presentations

Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.

Advertisements

Scaling up HIV services for women and children achievements and challenges e-lluminate session e-lluminate session Yves Souteyrand 2 March 2010.

TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn February 2005.

Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July Ties Boerma HIV Department Surveillance,

TB/HIV Research Priorities: TB Preventive Therapy.

TOWARDS UNIVERSAL ACCESS

Expert consultation on TB/HIV research priorities, February 2005 Mesdames et messieurs, soyez les bienvenus On behalf of the organizing committee.

Early Infant Diagnosis: Challenges and Solutions A special session IAS, Vienna 2010.

Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.

Accelerating Anti-Retroviral Treatment as a catalytic action for Ending AIDS Pride Chigwedere, MD, PhD Senior Advisor to the African Union AWA CONSULTATIVE.

Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.

Technical Advisory Group meeting, WHO/WPRO

HIV and AIDS Data Hub for Asia-Pacific Review in slides Children Last updated: February 2015.

Regional Integration in the Context of HIV and AIDS, TB and Malaria: The case of SADC Presentation at the XIX International AIDS Conference, Washington.

Module 7: Malaria and HIV/AIDS Palliative Care for People Living with HIV/AIDS.

Pediatric HIV Care & Treatment in Uganda A Five-Day Training Course For Health Professionals.

Title of Presentation 1 EU-ASEAN S&T cooperation to jointly tackle societal challenges Opportunities for future EU-ASEAN collaborations.

Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.

Creating an AIDS-Free Generation The beginning of the end of AIDS Center for Strategic & International Studies Washington, DC March 22, 2012 Thomas R.

Ilesh V. Jani, MD PhD Instituto Nacional de Saúde Maputo, Mozambique.

HIV/AIDS: A Global and Regional Perspective AIDS in Post 2015 Development Agenda.

Downloaded from Accelerate scaling up of TB/HIV activities in Tanzania Dr. N.G.SIMKOKO WHO/NTLP - Tanzania.

Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.

Evaluating the Effectiveness of the CTRC: Designing Quantitative and Qualitative Measures to Assess in Real Time the Value of the Center Mike Conlon, University.

WHO Expert Working Group on R&D Financing Stop TB New Tools Working Groups Marcos Espinal Executive Secretary.

The Strategic Use of ARVs | IAC Satellite, July 22, |1 | Strategic Use of Antiretroviral Drugs WHO Perspective for Future Guidelines Chair of WHO.

Nassau, The Bahamas 18 November 2011 The Status Of The HIV Epidemic In The Caribbean: Implications for research, surveillance and priority setting at country.

The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.

HIV and AIDS Data Hub for Asia-Pacific Review in slides Treatment Last updated: December 2014.

Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.

2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.

6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,

African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.

Resource Needs Model Rachel Sanders October 28 th, 2010.

Update of the Global Plan to Stop TB TB/HIV Working Group Meeting Geneva, November 2009 Christian Lienhardt.

End TB Strategy HCW with cough since January. Seen at government clinic thrice with no sputum/CXR. Diagnosed TB in May only.

Barriers to achieving the health MDGs and how these can be overcome Action for Global Health UK Policy Conference London, 28 June 2010 Isabelle de Zoysa.

TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.

HIV-infected subjects with CD4 350 to 550 cells/mm serodiscordant couples HPTN 052 Study Design Immediate ART CD Delayed ART CD4

INAT and Research Christian Lienhardt Stop TB Partnership Geneva First Meeting of the Core Group of the Subgroup on Introducing New Tools and Approaches.

Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.

Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.

HIV/AIDS Track Session. Key Points Application of international reference price list during a national tender is a valuable tool for achieving optimal.

Prevention of Mother to Child Transmission Antiretroviral Drugs to Prevent MTCT.

WORLD AIDS DAY Zero new HIV infections Zero discrimination Zero AIDS-related deaths.

Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.

Diagnostics - More than 100 years old Drugs – Last drug 40 years old Vaccine – Nearly 90 years old Lucica Ditiu Executive Secretary, Stop TB Partnership.

MDG 6: Combat HIV/AIDS and other diseases. Where are we…  Regionally, “on track” for MDG-6 (only a few countries are progressing slowly or show no progress)

The HIV Care Continuum: A Tool for Driving Systematic Change to Support Better Engagement in Care Jeffrey S. Crowley Distinguished Scholar/ Program Director.

Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.

Global Fund: Contributions to the Global Health Workforce 2 – 3 February 2012 Irish Forum for Global Health Conference.

PMTCT around the world Where are we? PMTCT Experts Roundtable Geneva, June 2008.

A Call to Action Children – The missing face of AIDS.

THE GLOBAL FUND SUSTAINING THE GAINS AND IMPACT Uganda November 2013.

Tuberculosis - the opportunity in our lifetime Dr. Lucica Ditiu | Executive Secretary | Stop TB Partnership 09.April.2013 | Brussels, Belgium.

2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.

THE GLOBAL FUND SUSTAINING THE GAINS AND IMPACT Uganda December 2013.

Contents Global impact 2.Service cascade 3. Policies and WHO support.

UNITAID Overview Joint Consultation on Seasonal Malaria Chemoprevention Ouagadougou, Burkina Faso, February 2017.

Sunday, 22 July, 07:30-20:00 Room Elicium 1, RAI Amsterdam

ДЭМБ, Сүрьеэтэй тэмцэх стратеги он: Бүсийн хэтийн төлөвлөгөө

Advanced HIV: a WHO perspective

Global Health Technology

and Prevent 100 Million Deaths from Cardiovascular Disease

The Global Fund to Fight AIDS, Tuberculosis and Malaria

Every Mother, Every Child: Closing the Gaps in HIV Management

The STOP TB Strategy – 2009 VISION: A TB-free world

A Time of Commitments and Actions to accelerate action to End TB

Surveillance, Monitoring and Evaluation Working Group

HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE

Presentation transcript:

Impact evaluation Evaluate new tools Translate new knowledge into policy and implementation Knowledge gap Program implementation

Research on HIV, TB and malaria achievements Globally, remarkable progress in control of HIV, TB and malaria in last two decades: millions of lives have been saved Progress made possible by research contributions to improved control: – HIV: discovery of anti-retroviral drugs; demonstrating their impact on transmission – TB: multidrug regimens, outcome monitoring – Malaria: ACT, insecticide-treated bed nets

KEMRI & CDC public health and research collaboration since 35 years 1. Insecticide-treated bed net trial informing global malaria control policy 2. Kisumu breastfeeding study informing PMTCT guidelines 3. HPTN 052: transmission impact of ARV: treatment as prevention 1. Lindblade et al JAMA Thomas et al PLoS Med Cohen et al. N Engl J Med 2011

Major challenges research response Despite progress, elimination of HIV, TB and malaria as public health threats still far away Ambitious sustainable development goals adopted (end epidemics…) Priority studies for KEMRI and CDC collaboration: – Population based studies on maximum impact of current tools – Clinical studies to evaluate new tools Other research priorities: – New tools development, operational research, social science research

Population based studies impact of current tools HIV: population impact of combined interventions in particular diagnosis and treatment TB: impact of improved case finding plus improved TB prevention (ART, LTBI treatment) Malaria: feasibility of pre- elimination in high transmission area NTDs: optimum delivery of MDA

Clinical studies evaluation of new tools HIV: PoC diagnostics; various drug trials (ARVs) and prevention trials (e.g. vaginal ring) TB: diagnostic platform; various drug trials (e.g. short course preventive therapy, new TB drugs, TB-HIV treatment), vaccine trials Malaria: low dose primaquine among children to reduce transmission NTDs: PoC diagnostics schistosomiasis Often multicentre, e.g. ACTG, TBTC

Conclusions Research relatively easy to translate into health programs, if this translation is considered in formulating research questions Major role for research in accelerating the control of communicable diseases in high- burden, low-income settings